Consensus Tempus AI, Inc.

Equities

TEM

US88023B1035

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-02-13 EST			5-day change	1st Jan Change
51.95 ^USD	+2.30%		-5.39%	-12.02%

02-12	Tempus AI, Inc. Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform	CI
01-27	Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits	MT

Evolution of the Average Target: Tempus AI, Inc.

Evolution of the Target Price: Tempus AI, Inc.

Changes in Analyst Recommendations: Tempus AI, Inc.

d50239823020aadf41c30c541e3bfed9.vxH9oaDMRkRuQgz5dmhkUkQx6EeLrJ5hX2N-NpXcwCA.3EaOysGvHAFZIUqePApQPiYJoHLtxO4LZlIHAaGU8lTneoTq1r8CKD17Zw~64e71b1daa3fc68bce0d669f5b0d39d3

Analysts' recommendations: Tempus AI, Inc.

12-02	Morgan Stanley Raises Price Target on Tempus AI to $85 From $80, Keeps Overweight Rating	MT
25-10-22	Analyst recommendations: 3M Company, Gartner, Halliburton, GM, Warner Bros Discovery…
25-10-21	Tempus AI Shares Lower After TD Cowen Downgrade	MT
25-04-21	BTIG Initiates Tempus AI at Buy With $60 Price Target	MT
25-02-26	Wolfe Research Downgrades Tempus AI to Peer Perform From Outperform	MT
25-02-25	JPMorgan Downgrades Tempus AI to Neutral From Overweight, Adjusts Price Target to $55 From $50	MT
25-02-12	William Blair Downgrades Tempus AI to Market Perform From Outperform	MT
25-01-07	President Capital Initiates Tempus AI at Buy With $52 Price Target	MT
24-12-09	Guggenheim Initiates Tempus AI at Buy With $74 Price Target	MT
24-11-11	Stifel Nicolaus Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $65 From $45	MT
24-10-02	BofA Securities Downgrades Tempus AI to Neutral From Buy on Valuation Price Target Raised to $60 From $45	MT
24-07-09	Wall Street analysts bullish on genetic testing firm Tempus AI	RE
24-07-09	Wall Street analysts bullish on genetic testing firm Tempus AI	RE
24-07-09	BofA Securities Starts Tempus AI With Buy Rating, $41 Price Target	MT
24-07-09	TD Cowen Initiates Tempus AI at Buy With $50 Price Target	MT
24-07-09	William Blair Initiates Tempus AI at Outperform	MT
24-07-09	Morgan Stanley Initiates Tempus AI at Overweight With $44 Price Target	MT
24-07-09	Stifel Initiates Tempus AI at Buy With $45 Price Target	MT
24-07-09	Needham Initiates Tempus AI at Buy With $47 Price Target	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

51.95USD

Average target price

87.92USD

Spread / Average Target

+69.23%

High Price Target

105.00USD

Spread / Highest target

+102.12%

Low Price Target

76.00USD

Spread / Lowest Target

+46.29%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
TD Cowen
Canaccord Genuity
HC Wainwright
BTIG
Wolfe Research
JPMorgan Chase
William Blair & Co.
President Capital Management
Guggenheim
Stifel Nicolaus
BofA Securities